Navigation Links
SynapDx Corporation Licenses Autism Diagnostic Discoveries From Children's Hospital Boston
Date:5/2/2011

SOUTHBOROUGH, Mass., May 2, 2011 /PRNewswire/ -- SynapDx Corporation announced today that is has obtained an exclusive world-wide license to technology from Children's Hospital Boston to accelerate the Company's development of blood-based tests to enable the early detection of Autism Spectrum Disorders. The discoveries were developed through collaboration by leading Children's researchers, Dr. Louis Kunkel and Dr. Isaac Kohane. In 2010, SynapDx also obtained exclusive world-wide rights to blood-based autism detection technologies from George Washington University, based on the work of Dr. Valerie Hu.

Dr. Kunkel is the Director of Children's Genomics Program and is credited with the discovery of the cause of Duchenne/Becker muscular dystrophy. Recently, he has turned his research towards better understanding the underlying causes of autism spectrum disorders.

Dr. Kohane is the Director of the Informatics program at Children's. His work combines the power of genomics and computer science to better understand brain development in autism spectrum disorders.

About SynapDx Corporation

SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control.

SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures and General Catalyst Partners. SynapDx's corporate headquarters is located in Southborough, MA. For more information, please visit: www.synapdx.com.


'/>"/>
SOURCE SynapDx Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
2. Pharmos Corporation Reports 2008 Second Quarter Results
3. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
4. Genaera Corporation Announces Second Quarter Financial Results
5. MannKind Corporation Reports Second Quarter Financial Results
6. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
7. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
10. Mymetics Corporation Important Shareholders Information Conference Call
11. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... research report with specific focus on US, EU, ... Japan , to the healthcare business intelligence ... library. Complete report on the Flow ... companies and supported with 282 tables and figures ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... lithography systems, announces the latest technology innovation for its Volume Pattern Generator (VPG) ... demand for production of advanced photomasks as well as a solution for mid ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based non-profit, ... grant from 1Plus12 Corporation. The grant will be used to further the scientific ... the organization's website http://www.ivsci.org , In accounting the grant to the ...
(Date:4/26/2016)... , April 26, 2016 genae, ... the medical industries, announced today the appointment of Prof. ... Officer. Prof. Balzer,s responsibilities will include all clinical, safety ... "We feel privileged and honored with the acceptance ... Bart Segers , CEO at genae. "Prof. Balzer,s impressive ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):